Page 640 - Williams Hematology ( PDFDrive )

614 Part VI: The Erythrocyte Chapter 41: Folate, Cobalamin, and Megaloblastic Anemias 615

434. Amos RJ, Amess JAL: Megaloblastic hematopoiesis due to acyclovir. Lancet 442. Isojarvi JIT, Pakarinen AJ, Myllyla VV: Basic haematological parameters, serum gam-
1(8318):242–243, 1983. maglutamyl-transferase activity, and erythrocyte folate and serum vitamin B-12 levels
435. Reyes P, Heidelberger C: Fluorinated pyrimidines. XXV. The inhibition of thymidylate during carbamazepine and oxcarbazepine therapy. Seizure 6(3):207–211, 1997.
synthetase from ehrlich ascites carcinoma cells by pyrimidine analogs. Biochim Biophys 443. Lindenbaum J, Whitehead N, Reyner F: Oral-contraceptive hormones, folate metabo-
Acta 103:177–179, 1965. lism, and cervical epithelium. Am J Clin Nutr 28(4):346–353, 1975.
436. Cornell RC, Milstein HG, Fox RM, Stoughton RB: Anemia of azaribine in the treatment 444. Heinivaa O, Palva IP: Malabsorption and deficiency of vitamin B12 caused by treatment
of psoriasis. Arch Dermatol 112(12):1717–1723, 1976. with para-aminosalicylic acid. Acta Med Scand 177(3):337–341, 1965.
437. Frenkel EP, Arthur C: Induced ribotide reductive conversion defect by hydroxyurea and 445. Callaghan TS, Hadden DR: Megaloblastic-anemia due to vitamin-B12 malabsorption
its relationship to megaloblastosis. Cancer Res 27(6):1016–1019, 1967. associated with long-term metformin treatment. BMJ 280(6225):1214–1215, 1980.
438. Papac RJ: Clinical and hematologic studies with 1-beta-D-arabinosylcytosine. J Natl 446. Webb DI, Chodos RB, Mahar CQ, Faloon WW: Mechanism of vitamin B12 malabsorp-
Cancer Inst 40(5):997, 1968. tion in patients receiving colchicine. N Engl J Med 279(16):845–850, 1968.
439. Druskin MS, Bohagura L, Wallen MH: Anticonvulsant-associated megaloblastic ane- 447. Dobbins WO, Herrero BA, Mansbach CM: Morphologic alterations associated with
mia. Response to 25 microgm. of folic acid administered by mouth daily. N Engl J Med neomycin induced malabsorption. Am J Med Sci 255: 63–77, 1968.
267(10):483–485, 1962. 448. Lerman BB, Ali N, Green D: Megaloblastic, dyserythropoietic anemia following arsenic
440. Gerson CD, Brown N, Herbert V, et al: Inhibition by diphenylhydantoin of folic-acid ingestion. Ann Clin Lab Sci 1980;10(6):515–517, 1968.
absorption in man. Gastroenterology 63(2):246, 1972.
441. Carl GF, Smith ML, Furman GM, et al: Phenytoin-treatment and folate supplementa-
tion affect folate concentrations and methylation capacity in rats. J Nutr 121(8):1214–
1221, 1991.

Kaushansky_chapter 41_p0583-0616.indd 615 9/17/15 6:24 PM